TSHA
Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Taysha Gene Therapies Inc. total liabilities for the quarter ending December 31, 2025 were 96.4M, a 8.49% increase year-over-year.
- Taysha Gene Therapies Inc. total liabilities for 2025 were 96.4M, a 8.49% increase from 2024.
- Taysha Gene Therapies Inc. total liabilities for 2024 were 88.8M, a 9.16% decrease from 2023.
- Taysha Gene Therapies Inc. total liabilities for 2023 were 97.8M, a 21.97% decrease from 2022.
- Taysha Gene Therapies Inc. total liabilities for 2022 were 125.3M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Taysha Gene Therapies Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $96 |
| 2024 | $89 |
| 2023 | $98 |
| 2022 | $125 |
| Taysha Gene Therapies Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $96 |
| 2024-12-31 | $89 |
| 2023-12-31 | $98 |
| 2022-12-31 | $125 |
Taysha Gene Therapies Inc. Total Liabilities — FAQ
Taysha Gene Therapies Inc. (TSHA) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's total liabilities history?
The chart and table above show Taysha Gene Therapies Inc.'s total liabilities by year and by quarter, including the growth rate.